Form 4: Humana CLO Reports Routine Stock Vesting and Tax Sales
Insider Transaction Report
Humana's Chief Legal Officer, Joseph C. Ventura, reported the acquisition of 1,035 shares and the disposition of 478 shares for tax purposes following the vesting of performance stock units.
Summary
- Joseph C. Ventura, Humana Inc.'s Chief Legal Officer, reported transactions involving Humana Common Stock.
- Acquired 1,035 shares of Humana Common Stock on February 24, 2026, at a price of $0, related to the vesting of Performance Stock Units.
- Disposed of 478 shares of Humana Common Stock on February 24, 2026, at a price of $177.075 per share, to cover tax liabilities associated with the vested performance stock units.
- Following these transactions, Ventura directly beneficially owns 17,087 shares, which includes 6,250 restricted stock units.
- Ventura also indirectly beneficially owns 289 shares through the Humana Retirement Savings Plan.
- The filing also details existing derivative securities, including various tranches of stock options with exercise prices ranging from $350.7875 to $510.2425 and expiration dates between February 2027 and February 2031.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as the vesting of performance stock units indicates the achievement of company goals, and the insider maintains a substantial direct and indirect ownership stake, aligning interests with shareholders.
Positives
- Vesting of 1,035 performance stock units indicates achievement of performance targets.
- Continued significant direct beneficial ownership of 17,087 shares, demonstrating alignment with shareholder interests.
- Holding of 289 shares indirectly through the Humana Retirement Savings Plan.
- Multiple tranches of stock options held, providing further incentive for long-term company performance.
Negatives
- Disposition of 478 shares to cover tax liabilities, which is a routine event for vested equity awards and not indicative of a negative outlook.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding Humana Inc.'s future performance or strategic direction.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as the vesting of performance stock units and subsequent sale of shares to cover tax obligations, are common occurrences in the healthcare industry for executive compensation. These transactions generally do not signal a change in management's outlook on the company's prospects but rather reflect the standard operation of equity incentive plans.
Stakeholder Impact
- Shareholders: The vesting of performance stock units suggests that company performance targets were met, which is generally positive for shareholders. The insider's continued significant ownership aligns their interests with other shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/24/2020 | Grant date for 4,656 stock options, vesting in three annual increments from 2/24/21 to 2/24/23. |
| 02/22/2021 | Grant date for 4,598 stock options, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 02/21/2022 | Grant date for 3,932 stock options, vesting in three annual increments from 2/21/23 to 2/21/25. |
| 02/24/2023 | Grant date for 4,162 stock options, vesting in three annual increments from 2/24/24 to 2/24/26. |
| 02/21/2024 | Grant date for 6,572 stock options, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 01/31/2026 | Date as of which shares were held for the benefit of the reporting person under the Humana Retirement Savings Plan. |
| 02/24/2026 | Date of earliest transaction, including vesting of performance stock units and disposition of shares for tax liability. |
| 02/26/2026 | Signature date of the reporting person. |
| 02/24/2027 | Expiration date for 4,656 stock options granted on 02/24/2020. |
| 02/22/2028 | Expiration date for 4,598 stock options granted on 02/22/2021. |
| 02/21/2029 | Expiration date for 3,932 stock options granted on 02/21/2022. |
| 02/24/2030 | Expiration date for 4,162 stock options granted on 02/24/2023. |
| 02/21/2031 | Expiration date for 6,572 stock options granted on 02/21/2024. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of performance stock units and the sale of shares to cover tax obligations. Such transactions are standard and do not typically indicate a change in the company's fundamental outlook or warrant a shift in investment strategy. The insider maintains a substantial ownership stake, which is a positive for alignment, but the filing itself does not provide new information to alter a 'hold' recommendation.
Keywords
Humana, HUM, Joseph C. Ventura, Chief Legal Officer, Insider Trading, Form 4, Stock Options, Performance Stock Units, Equity Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.